Stoke Therapeutics, Inc.

STOK · Nasdaq · SIC 2834: Pharmaceutical Preparations
124
SEC Filings

Business Summary

1 Item 1A. Risk Factors 31 Item 1B. Unresolved Staff Comments 71 Item 1C. Cybersecurity 71 Item 2. Properties 73 Item 3. Legal Proceedings 73 Item 4. Mine Safety Disclosures 73 PART II Item 5. Market for Registrants Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities 74 Item 6. [Reserved] 74 Item 7. Managements Discussion and Analysis of Financial Condition and Results of Operations 75 Item 7A. Quantitative and Qualitative Disclosures About Market Risk 88 Item 8....

Next Earnings

Q2 FY2026 — expected 2026-08-09

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionSTOKdiscussed_in_filing Cybersecurity
topic_mentionSTOKdiscussed_in_filing Cybersecurity
topic_mentionSTOKdiscussed_in_filing Cybersecurity
topic_mentionSTOKdiscussed_in_filing Cybersecurity

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-162025-12-310001193125-26-108362EDGAR93K words
2025-03-182024-12-310000950170-25-041170EDGAR—
2024-03-252023-12-310000950170-24-035912EDGAR—
2023-03-062022-12-310001564590-23-003175EDGAR—
2022-03-102021-12-310001564590-22-009634EDGAR—
2021-03-092020-12-310001564590-21-011760EDGAR—
2020-03-232019-12-310001564590-20-012202EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-042025-09-300001193125-25-264720EDGAR61K words
2025-08-122025-06-300000950170-25-107332EDGAR—
2025-05-132025-03-310000950170-25-070296EDGAR—
2024-11-052024-09-300000950170-24-121445EDGAR—
2024-08-072024-06-300000950170-24-092738EDGAR—
2024-05-062024-03-310000950170-24-053535EDGAR—
2023-11-072023-09-300000950170-23-060224EDGAR—
2023-08-072023-06-300000950170-23-039050EDGAR—
2023-05-042023-03-310000950170-23-017839EDGAR—
2022-11-142022-09-300001564590-22-037497EDGAR—
2022-08-082022-06-300001564590-22-028440EDGAR—
2022-05-102022-03-310001564590-22-019268EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-270001193125-26-129168EDGAR1K words
2026-03-030001193125-26-088205EDGAR—
2026-01-260001193125-26-022569EDGAR—
2026-01-120001193125-26-009781EDGAR—
2025-12-050001193125-25-308781EDGAR—
2025-11-040001193125-25-264644EDGAR—
2025-10-060001193125-25-230925EDGAR—
2025-08-120000950170-25-107275EDGAR—
2025-08-110001193125-25-177433EDGAR—
2025-07-100001193125-25-157364EDGAR—

124 total filings indexed. 95 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001623526
TickerSTOK
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 6a9377a35efb64927b17a554ea6a2f842828a1604e8891705cbef1f17fd8c333
parent: 3683d1b19636c671f76c9f20fd8d16de1d3c2c1c173cc8513f967375b62aae06
content hash: cb0ec354c184ff59dfb23c65e62ac1f14204bf9b2b877a2fb32f1b9273ad5b53
signed: 2026-04-13T04:47:38.742Z
sources: 19 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf